IND submission for intranasal SPC-15 treatment expected in 2025; Phase 1 clinical trial to follow upon approval SP-26 ketamine implants nearing first animal studies SARASOTA, FL, Jan. 02, 2025 (GLOBE ...
REHOVOT, Israel, July 23, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (PPBT) ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that ...
Longeveron announces CEO's letter detailing progress on stem cell therapies for Alzheimer’s disease and Hypoplastic Left Heart Syndrome. Longeveron Inc. has announced progress in its cellular therapy ...
This letter to the editor presents an in-depth overview of the current state of Nipah virus (NiV) vaccine development, highlighting both scientific advancements and critical challenges that still ...
Human development progress is experiencing an unprecedented slowdown according to a new report released Tuesday by the United Nations Development Programme (UNDP). The report showed how Artificial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results